Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee 37221, USA.
J Biol Chem. 2010 May 7;285(19):14115-21. doi: 10.1074/jbc.M110.112672. Epub 2010 Mar 11.
The Na-K-2Cl cotransporter (NKCC1) participates in epithelial transport and in cell volume maintenance by mediating the movement of ions and water across plasma membranes. Functional studies have previously demonstrated that NKCC1 activity is stimulated by protein phosphatase 1 (PP1) inhibitors. In this study, we utilized both in vivo (heterologous cRNA expression in Xenopus laevis oocytes) and in vitro ((32)P-phosphorylation assays with glutathione S-transferase fusion proteins) experiments to determine whether PP1 exerts its inhibitory effect directly on the cotransporter, or indirectly by affecting the activating kinase. We found that PP1 reduced NKCC1 activity in oocytes under both isotonic and hypertonic conditions to the same level as in water-injected controls. Interestingly, mutation of key residues in the PP1 binding motif located in the N-terminal tail of NKCC1 significantly reduced the inhibitory effect of PP1. In vitro experiments performed with recombinant PP1, SPAK (Ste20-related proline/alanine-rich kinase, which activates NKCC1), and the N terminus of NKCC1 fused to glutathione S-transferase demonstrated that PP1 dephosphorylated both the kinase and the cotransporter in a time-dependent manner. More importantly, PP1 dephosphorylation of SPAK was significantly greater when protein-protein interaction between the kinase and the N-terminal tail of NKCC1 was present in the reaction, indicating the necessity of scaffolding the phosphatase and kinase in proximity to one another. Taken together, our data are consistent with PP1 inhibiting NKCC1 activity directly by dephosphorylating the cotransporter and indirectly by dephosphorylating SPAK.
钠钾 2 氯协同转运蛋白(NKCC1)通过介导离子和水穿过质膜的运动参与上皮转运和细胞体积维持。功能研究先前表明,NKCC1 活性受蛋白磷酸酶 1(PP1)抑制剂的刺激。在这项研究中,我们利用体内(非洲爪蟾卵母细胞中的异源 cRNA 表达)和体外实验(谷胱甘肽 S-转移酶融合蛋白的(32)P-磷酸化测定)来确定 PP1 是否直接对协同转运蛋白发挥抑制作用,还是通过影响激活激酶间接发挥作用。我们发现,PP1 在等渗和高渗条件下均降低卵母细胞中 NKCC1 的活性,使其达到与水注射对照相同的水平。有趣的是,位于 NKCC1 N 端尾部的 PP1 结合基序中的关键残基突变显著降低了 PP1 的抑制作用。用重组 PP1、SPAK(激活 NKCC1 的丝氨酸/苏氨酸相关脯氨酸/丙氨酸丰富激酶)和与谷胱甘肽 S-转移酶融合的 NKCC1 N 端进行的体外实验表明,PP1 以时间依赖的方式使激酶和协同转运蛋白去磷酸化。更重要的是,当激酶和 NKCC1 N 端之间存在蛋白质-蛋白质相互作用时,PP1 对 SPAK 的去磷酸化作用明显更大,表明需要将磷酸酶和激酶支架在彼此附近。综上所述,我们的数据表明,PP1 通过使协同转运蛋白去磷酸化直接抑制 NKCC1 活性,通过使 SPAK 去磷酸化间接抑制 NKCC1 活性。